ECB-ART-49233
Antiviral Res
2021 Jun 01;190:105077. doi: 10.1016/j.antiviral.2021.105077.
Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus.
Zoepfl M
,
Dwivedi R
,
Taylor MC
,
Pomin VH
,
McVoy MA
.
???displayArticle.abstract???
Broad-spectrum antivirals are more needed than ever to provide treatment options for novel emerging viruses and for viruses that lack therapeutic options or have developed resistance. A large number of viruses rely on charge-dependent non-specific interactions with heparan sulfate (HS), a highly sulfated glycosaminoglycan (GAG), for attachment to cell surfaces to initiate cell entry. As such, inhibitors targeting virion-HS interactions have potential to have broad-spectrum antiviral activity. Previous research has explored organic and inorganic small molecules, peptides, and GAG mimetics to disrupt virion-HS interactions. Here we report antiviral activities against both enveloped (the herpesvirus human cytomegalovirus) and non-enveloped (adenovirus) DNA viruses for four defined marine sulfated glycans: a sulfated galactan from the red alga Botryocladia occidentalis; a sulfated fucan from the sea urchin Lytechinus variegatus, and a sulfated fucan and a fucosylated chondroitin sulfate from the sea cucumber Isostichopus badionotus. As evidenced by gene expression, time of addition, and treatment/removal assays, all four novel glycans inhibited viral attachment and entry, most likely through interactions with virions. The sulfated fucans, which both lack anticoagulant activity, had similar antiviral profiles, suggesting that their activities are not only due to sulfation content or negative charge density but also due to other physicochemical factors such as the potential conformational shapes of these carbohydrates in solution and upon interaction with virion proteins. The structural and chemical properties of these marine sulfated glycans provide unique opportunities to explore relationships between glycan structure and their antiviral activities.
???displayArticle.pubmedLink???
33864843
???displayArticle.pmcLink???
PMC8212419
???displayArticle.link???
Antiviral Res
???displayArticle.grants???
[+]
References [+] :
Aquino,
Glycosaminoglycans and infection.
2016,
Pubmed
Aquino,
Glycosaminoglycans and infection.
2016,
Pubmed
ASTRUP,
Polysaccharide polysulphuric acids as antihyaluronidases.
1950,
Pubmed
Baba,
Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus.
1988,
Pubmed
Badani,
Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity.
2014,
Pubmed
Bezerra,
Conformational properties of l-fucose and the tetrasaccharide building block of the sulfated l-fucan from Lytechinus variegatus.
2020,
Pubmed
,
Echinobase
Busso,
Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides.
1990,
Pubmed
Cagno,
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
2019,
Pubmed
Chen,
Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus.
2012,
Pubmed
,
Echinobase
Christensen,
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate.
2001,
Pubmed
Compton,
Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.
1993,
Pubmed
Cui,
Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine.
2012,
Pubmed
Dechecchi,
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.
2001,
Pubmed
De Clercq,
Antiviral therapy for human immunodeficiency virus infections.
1995,
Pubmed
De Clercq,
Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.
1979,
Pubmed
De Clercq,
Suramin in the treatment of AIDS: mechanism of action.
1987,
Pubmed
de Paiva,
What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks.
2020,
Pubmed
Donalisio,
Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition.
2014,
Pubmed
Duan,
A faster immunofluorescence assay for tracking infection progress of human cytomegalovirus.
2012,
Pubmed
Farias,
Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates.
2000,
Pubmed
Farndale,
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.
1986,
Pubmed
Farndale,
A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.
1982,
Pubmed
Gandhi,
The structure of glycosaminoglycans and their interactions with proteins.
2008,
Pubmed
GERBER,
Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus.
1958,
Pubmed
Halpern,
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.
2008,
Pubmed
Hao,
Marine glycan-based antiviral agents in clinical or preclinical trials.
2019,
Pubmed
He,
A simplified system for generating recombinant adenoviruses.
1998,
Pubmed
Herold,
Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases.
2000,
Pubmed
Ibig-Rehm,
High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells.
2011,
Pubmed
Ito,
Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.
1987,
Pubmed
Mauck,
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
2004,
Pubmed
McVoy,
Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome.
1999,
Pubmed
Mercorelli,
Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus.
2010,
Pubmed
Mitsuya,
Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.
1988,
Pubmed
Mulloy,
Sulfated fucans from echinoderms have a regular tetrasaccharide repeating unit defined by specific patterns of sulfation at the 0-2 and 0-4 positions.
1994,
Pubmed
,
Echinobase
Nakashima,
Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica.
1987,
Pubmed
Neurath,
Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.
2002,
Pubmed
Oduah,
Heparin: Past, Present, and Future.
2016,
Pubmed
Paeschke,
DSTP-27 prevents entry of human cytomegalovirus.
2014,
Pubmed
Pomin,
Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals.
2015,
Pubmed
Pomin,
Fucanomics and galactanomics: marine distribution, medicinal impact, conceptions, and challenges.
2012,
Pubmed
Pomin,
Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures.
2012,
Pubmed
Pomin,
Specific sulfation and glycosylation-a structural combination for the anticoagulation of marine carbohydrates.
2014,
Pubmed
,
Echinobase
Pomin,
Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity.
2005,
Pubmed
,
Echinobase
Pomin,
Mild acid hydrolysis of sulfated fucans: a selective 2-desulfation reaction and an alternative approach for preparing tailored sulfated oligosaccharides.
2005,
Pubmed
,
Echinobase
Pomin,
Antimicrobial Sulfated Glycans: Structure and Function.
2017,
Pubmed
Queiroz,
Oligosaccharides from the 3-linked 2-sulfated alpha-L-fucan and alpha-L-galactan show similar conformations but different dynamics.
2016,
Pubmed
Quinderé,
Is the antithrombotic effect of sulfated galactans independent of serpin?
2014,
Pubmed
Qureshi,
AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses.
2014,
Pubmed
Santos,
Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs.
2014,
Pubmed
Schmidtke,
Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.
2003,
Pubmed
Selinka,
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
2007,
Pubmed
Shoup,
Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry.
2020,
Pubmed
Skoler-Karpoff,
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
2008,
Pubmed
Stevic,
Binding of heparin to metals.
2011,
Pubmed
Van Damme,
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
2008,
Pubmed
Varnum,
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.
2004,
Pubmed
Vasconcelos,
Anticoagulant and Antithrombotic Properties of Three Structurally Correlated Sea Urchin Sulfated Glycans and Their Low-Molecular-Weight Derivatives.
2018,
Pubmed
,
Echinobase
Wang,
Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism.
2005,
Pubmed
Xiao,
Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells.
2003,
Pubmed
Xiao,
Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.
2002,
Pubmed
Yao,
The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin.
1991,
Pubmed
Zaneveld,
Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate).
2002,
Pubmed
